Corrigendum to "Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch" [Redox Biol. 52 (2022) 1-16/102311].

Mingge Ding Rui Shi Shuli Cheng Man Li Dema De Chaoyang Liu Xiaoming Gu Juan Li Shumiao Zhang Min Jia Rong Fan Jianming Pei Feng Fu

Redox Biol

Department of Physiology and Pathophysiology, National Key Discipline of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China. Electronic address:

Published: June 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108085	PMC
http://dx.doi.org/10.1016/j.redox.2022.102315	DOI Listing

Publication Analysis

Top Keywords

corrigendum "mfn2-mediated

"mfn2-mediated mitochondrial

mitochondrial fusion

fusion alleviates

alleviates doxorubicin-induced

doxorubicin-induced cardiotoxicity

cardiotoxicity enhancing

enhancing anticancer

anticancer activity

activity metabolic

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!